跳至主要内容
临床试验/NCT05968183
NCT05968183招募中不适用

The Value of HPV Testing for Cervical Cancer Screening in Women Living With HIV

Centre Hospitalier de Saint-Denis1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Demographic characteristics

研究概览

简要总结

The main objective of this study is to evaluate the interest of a screening strategy based on the HPV test in patients living with HIV, compared to the cell smear alone in the same population.

The Secondary objective of this study is to verify if the use of HPV testing could allow for a longer follow-up of these patients in case of negativity, and thus allow for a standardization of clinicians' practices.

详细描述

Since 2019, a new screening strategy has been implemented and is based on high-risk, HPV tests, which, when negative, allow for spaced monitoring in the general population after age 30 (every 5 years instead of every 3 years.)

These tests therefore allow for earlier detection of patients at risk but also for longer follow-up when they are negative.

To our knowledge, there is currently no evaluation of HPV testing as part of routine screening in patients living with HIV.

The recommendations for this population are based on the use of the cervico-vaginal smear with cytological analysis. The smear should be taken every year and surveillance may be repeated every 3 years. If there are 3 consecutive smears without abnormalities and a controlled viral load with CD4 counts > 500 mm3. In practice, many patients do not meet these criteria and must, therefore, undergo annual screening; the increase in the number of smears also leads to an increase in the number of second-line examinations such as colposcopy.

Since there is no recommendation for HPV testing in this population, the use of dual detection (cytology and HPV testing) is left to the discretion of the clinician.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women living with HIV
  • Age 25-65 years
  • Managed in the CHSD maternity ward: consultation or hospitalization
  • Having signed a consent form

排除标准

  • Age ≤ 24 years, or ≥ 66 years
  • Women who are not HIV positive
  • Patients under legal protection (guardianship, curatorship)
  • Patients deprived of liberty
  • Patients not affiliated to a social security system
  • Refusal to participate in the research

结局指标

主要结局

Demographic characteristics

时间窗: Day 1

comorbidities

时间窗: Day 1

clinical examination data

时间窗: Day 1

HIV history

时间窗: Day 1

medical history

时间窗: Day 1

次要结局

  • Results of cell smear(Day 1)
  • Results of HPV Cytology(Day 1)
  • Results of additional examinations prescribed(Day 1)

研究者

发起方
Centre Hospitalier de Saint-Denis
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验